Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01475877 · ClinicalTrials.gov registry record
Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy
A clinical trial of Myopia, sponsored by Virdi Eye Clinic.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT01475877: Completed study of Myopia, sponsored by Virdi Eye Clinic.
NCT01475877 is a study of Myopia that has completed, run by Virdi Eye Clinic. The registered enrollment target is 20 participants, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01475877, a study of Myopia, has completed, sponsored by Virdi Eye Clinic.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.
Conditions Studied
Interventions
- DRUG Bromfenac
Study Locations (1)
Illinois
- Virdi Eye Clinic and Laser Vision Center - Rock Island
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-05 |
What the finished NCT01475877 record still lists
NCT01475877 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 268-participant average among 90 other Myopia trials with a reported enrollment target (93% lower).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which Bromfenac is the first listed.
NCT01475877 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT01475877 about?
NCT01475877 is a clinical study titled "Bromday Versus Nevanac Eye Drops to Control Pain Following Photorefractive Keratectomy". This study will compare the effect of two topical non-steroidal antiinflammatory agents to control pain after photorefractive keratectomy (PRK) eye surgery.
What is the current status of trial NCT01475877?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2011-05. Estimated completion is 2012-05.
What conditions does trial NCT01475877 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT01475877?
The interventions under investigation include: Bromfenac (DRUG).
Who is sponsoring clinical trial NCT01475877?
This trial is sponsored by Virdi Eye Clinic, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01475877 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01475877's enrollment target sits among peer trials
20 88th of 90 higher than 2 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia